D.E. Shaw & Co’s ResMed RMD Stock Holding History

D.E. Shaw & Co’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-30,000	Closed	-$7.32M	–	4794
2024 Q3	$7.32M	Hold	30,000	–	–	0.01%	1650
2024 Q2	$5.74M	Hold	30,000	–	–	0.01%	1742
2024 Q1	$5.94M	Hold	30,000	–	–	0.01%	1762
2023 Q4	$5.16M	Buy	30,000 +20,000	+200%	+$3.07M	﹤0.01%	1881
2023 Q3	$1.48M	Buy	+10,000	New	+$1.81M	﹤0.01%	2816
2022 Q2	–	Sell	-1,700	Closed	-$412K	–	5709
2022 Q1	$412K	Hold	1,700	–	–	﹤0.01%	4482
2021 Q4	$443K	Hold	1,700	–	–	﹤0.01%	4469
2021 Q3	$448K	Buy	+1,700	New	+$465K	﹤0.01%	4153
2020 Q3	–	Sell	-7,700	Closed	-$1.48M	–	4106
2020 Q2	$1.48M	Sell	7,700 -19,000	-71%	-$3.11M	﹤0.01%	2645
2020 Q1	$3.93M	Buy	26,700 +7,700	+41%	+$1.23M	0.01%	1644
2019 Q4	$2.94M	Buy	19,000 +4,100	+28%	+$591K	﹤0.01%	2164
2019 Q3	$2.01M	Buy	+14,900	New	+$1.95M	﹤0.01%	2343

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

D.E. Shaw & Co's RMD Position: Q2 2026 in Review

D.E. Shaw & Co reduced its ResMed (RMD) stake by 47% in Q2 2026, selling an estimated $1.13M and leaving 6,121 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #3622.

D.E. Shaw & Co first reported a position in RMD in Q2 2013 and has held it in 45 quarters since. The position peaked at $97.2M in Q3 2023. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

D.E. Shaw & Co held 6,121 shares of ResMed worth $1.19M as of Q2 2026.
D.E. Shaw & Co sold 5,455 ResMed shares in Q2 2026, an estimated $1.13M.
ResMed made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #3622 holding.
D.E. Shaw & Co first reported a position in ResMed in Q2 2013 and has held it in 45 quarters since.
D.E. Shaw & Co's ResMed position peaked at $97.2M in Q3 2023.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.